Prosecution Insights
Last updated: April 19, 2026

Leason Ellis LLP (Life Sciences)

13 pending office actions • 9 clients

Portfolio Summary

13
Total Pending OAs
2
Final Rejections
11
Non-Final OAs

Client Portfolio (9 clients)

Client (Assignee)Pending OAs
Agenebio, Inc. 4
Sage Therapeutics, Inc. 2
University of San Diego 1
Sangamo Therapeutics, Inc. 1
Sumitomo Pharma Co., Ltd. 1
Sage Therapeutics, Inc. 1
Atsuo Ochi 1
BIONTECH SE 1
Ladrx Corporation 1

Pending Office Actions

App #TitleClientExaminerArt UnitStatusFiled
18730413 COMPOSITIONS AND METHODS FOR DELIVERY OF NUCLEIC ACIDS University of San Diego ARNOLD, ERNST V 1613 Non-Final OA Jul 19, 2024
18235753 BENZAZEPINE DERIVATIVES, COMPOSITIONS, AND METHODS FOR TREATING COGNITIVE IMPAIRMENT Agenebio, Inc. HERNANDEZ, JACKSON J 1627 Non-Final OA Aug 18, 2023
18216057 OXYSTEROLS AND METHODS OF USE THEREOF Sage Therapeutics, Inc. HOWELL, THEODORE R 1628 Final Rejection Jun 29, 2023
18201885 CYP46A1 INHIBITORS AND METHODS OF USE THEREOF Sage Therapeutics, Inc. MOU, LIYUAN 1628 Non-Final OA May 25, 2023
18029806 METHODS OF DETECTING ANTI-AAV ANTIBODIES Sangamo Therapeutics, Inc. HILL, MYRON G 1671 Non-Final OA Mar 31, 2023
18113887 THERAPEUTIC DRUG FOR MOTOR COMPLICATIONS IN PARKINSON'S DISEASE Sumitomo Pharma Co., Ltd. NOTTINGHAM, KYLE GREGORY 1621 Non-Final OA Feb 24, 2023
18015439 COMBINATIONS OF GABAA ALPHA 5 AGONISTS AND SV2A INHIBITORS AND METHODS OF USING IN THE TREATMENT OF COGNITIVE IMPAIRMENT Agenebio, Inc. WHITE, DAWANNA SHAR-DAY 1627 Non-Final OA Jan 10, 2023
18015445 POLYMORPHS OF A GABAA ALPHA5 AGONIST AND METHODS OF USING IN THE TREATMENT OF COGNITIVE IMPAIRMENT Agenebio, Inc. BURKETT, DANIEL JOHN 1624 Non-Final OA Jan 10, 2023
17947844 NEUROACTIVE COMPOUNDS AND METHODS OF USE THEREOF Sage Therapeutics, Inc. KLINKEL, KORTNEY L 1627 Non-Final OA Sep 19, 2022
17786175 BENZODIAZEPINE DERIVATIVES, COMPOSITIONS, AND METHODS FOR TREATING COGNITIVE IMPAIRMENT Agenebio, Inc. CHONG, YONG SOO 1623 Non-Final OA Jun 16, 2022
17775801 METHODS AND A KIT TO REPROGRAM SOMATIC CELLS Atsuo Ochi RAHMAN, MASUDUR 1633 Non-Final OA May 10, 2022
17609358 NOVEL GARDNERELLA ENDOLYSINS AND USES THEREOF BIONTECH SE EDWARDS, JESSICA FAYE 1657 Non-Final OA Nov 05, 2021
17262133 IMAGING AGENTS FOR RADIOLABELING EXOGENOUS AND ENDOGENOUS ALBUMIN Ladrx Corporation SCHLIENTZ, LEAH H 1618 Final Rejection Jan 21, 2021

Managing Leason Ellis LLP (Life Sciences)'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month